News
Lhasa Limited releases new data to its Vitic Intermediates Project users
06 June 2019
Lhasa Limited is pleased to announce the release of new data to its Vitic Intermediates project members.
Lhasa Limited releases new data to its Vitic Excipients Project users
06 June 2019
Lhasa Limited is pleased to announce the release of new data to its Vitic Excipients project members.
Setaria users benefit from updated functionality
31 May 2019
Lhasa Limited is pleased to announce the addition of Setaria to its product portfolio. Developed in collaboration with members of the pharmaceutical industry, Setaria is a project-centric, knowledge-searchable database for the storage of toxicity data to manage impurity assessments under ICH M7.
Prototype Application Released for Lhasa’s Defined Approach for Skin Sensitisation
30 May 2019
Use the application now to get a hazard and potency prediction for your compounds of interest.
New approaches of chemical safety assessment discussed between regulatory experts and the researchers of EU-ToxRisk
28 May 2019
An international workshop was held in Espoo, Finland in May and was organised collaboratively by EU-ToxRisk and regulatory representatives (e.g. ECHA, EFSA, OECD, EPA). Altogether, a group of more than 60 international experts from industry, academia and regulatory authorities came to Finland to discuss a total of five scientifically advanced project case studies developed within EU-ToxRisk, the OECD/IATA program, and NIHS Japan.
First Biotech Member Realises the Benefits of Vitic through SaaS in the Lhasa Cloud
28 January 2019
Idorsia Pharmaceuticals Ltd. Realises the Benefits of Vitic through SaaS in the Lhasa Cloud.
Lhasa Limited releases new data for the iPiE Project
12 December 2018
New data has been added to the iPiE (Intelligent Assessment of Pharmaceuticals in the Environment) database this month.
AstraZeneca Becomes the First Lhasa Member to Realise the Benefits of Mirabilis through SaaS
04 October 2018
Lhasa Limited, an educational charity which creates state-of-the-art in silico prediction and database systems, today announced that AstraZeneca has become the first organisation to adopt Mirabilis through Software as a Service (SaaS).
Lhasa Limited: Enabling ICH compliance through our products
08 August 2018
In light of the wide adoption of ICH M7 (R1), this article discusses some of the ways Lhasa can support you with other international guidelines.
